|
FBXO4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.64760435797484E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.62589999428565E-11 |
| Normal-vs-Stage2 |
5.341200E-03 |
| Normal-vs-Stage3 |
1.5811299999946E-05 |
| Normal-vs-Stage4 |
1.439520E-04 |
| Stage1-vs-Stage2 |
3.564800E-01 |
| Stage1-vs-Stage3 |
4.257000E-01 |
| Stage1-vs-Stage4 |
7.472000E-01 |
| Stage2-vs-Stage3 |
7.669400E-01 |
| Stage2-vs-Stage4 |
6.217400E-01 |
| Stage3-vs-Stage4 |
7.635800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.59738930153253E-12 |
| Normal-vs-AfricanAmerican |
7.577900E-02 |
| Normal-vs-Asian |
9.643600E-04 |
| Caucasian-vs-AfricanAmerican |
3.217700E-02 |
| Caucasian-vs-Asian |
7.016600E-01 |
| AfricanAmerican-vs-Asian |
2.121200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.37192512695128E-12 |
| Normal-vs-Female |
1.71534999999778E-05 |
| Male-vs-Female |
5.106000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.430400E-02 |
| Normal-vs-Age(41-60Yrs) |
4.91410000025283E-07 |
| Normal-vs-Age(61-80Yrs) |
1.11110010081461E-11 |
| Normal-vs-Age(81-100Yrs) |
3.057500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.734200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.071980E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.552400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.651730E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.401800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.924200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.533600E-02 |
| Normal-vs-Grade 2 |
1.14569465026193E-11 |
| Normal-vs-Grade 3 |
1.06709999725396E-08 |
| Normal-vs-Grade 4 |
1.638200E-02 |
| Grade 1-vs-Grade 2 |
2.380000E-02 |
| Grade 1-vs-Grade 3 |
7.167900E-02 |
| Grade 1-vs-Grade 4 |
8.889400E-01 |
| Grade 2-vs-Grade 3 |
5.226600E-01 |
| Grade 2-vs-Grade 4 |
2.080200E-02 |
| Grade 3-vs-Grade 4 |
9.757900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.1449508835758E-13 |
| Normal-vs-ccB subtype |
8.02600000000542E-05 |
| ccA subtype-vs-ccB subtype |
1.160300E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.69099997629985E-09 |
| Normal-vs-N1 |
5.487800E-01 |
| N0-vs-N1 |
1.400200E-01 |
|
|
